Overview
- Moolec’s latest SEC filings confirm Bioceres SA’s voluntary creditors’ proceeding approved on December 16, 2025, with loss of control and an expected court-appointed trustee to oversee the process.
- Under IFRS 10, Moolec expects non-cash gains of about $91 million from Bioceres SA and $5.3 million from Bioceres LLC due to deconsolidation effects.
- The restructuring severs ties with Nasdaq-listed Bioceres Crop Solutions (BIOX), after creditors auctioned 3.06 million pledged BIOX shares linked to Bioceres LLC.
- Luxembourg vehicle Theo I SCSp entered bankruptcy on November 28, 2025, generating an additional $9.5 million accounting gain from deconsolidation.
- Moolec completed a 15-for-1 reverse stock split on January 5, 2026, while Bioceres SA remains burdened by more than ARS 9.4 billion in outstanding promissory notes.